{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:22:17Z","timestamp":1770747737219,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008637","name":"National Cancer Institute Center for Strategic Scientific Initiatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029645","name":"North American Neuroendocrine Tumor Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.clinimag.2025.110463","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:58:17Z","timestamp":1743217097000},"page":"110463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Safety and efficacy of transarterial therapies for pancreatic acinar cell carcinoma metastases"],"prefix":"10.1016","volume":"121","author":[{"given":"Harrison","family":"Blume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etay","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlasios","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2025.110463_bb0005","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.3748\/wjg.v12.i20.3180","article-title":"Less common neoplasms of the pancreas","volume":"12","author":"Mulkeen","year":"2006","journal-title":"WJG"},{"key":"10.1016\/j.clinimag.2025.110463_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/mpa.0b013e31804bfbd3","article-title":"Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from pancreatic cancer registry of Japan pancreas society","volume":"35","author":"Kitagami","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.clinimag.2025.110463_bb0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semdp.2019.07.001","article-title":"Lipase hypersecretion syndrome: a distinct form of paraneoplastic syndrome specific to pancreatic acinar carcinomas","volume":"36","author":"Taskin","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jjco\/hyad176","article-title":"Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment","volume":"54","author":"Ikezawa","year":"2024","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0025","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1634\/theoncologist.2011-0231","article-title":"Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy","volume":"16","author":"Lowery","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.clinimag.2025.110463_bb0030","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00432-016-2264-7","article-title":"Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma","volume":"142","author":"Kruger","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0035","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s11605-008-0705-6","article-title":"Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma","volume":"12","author":"Schmidt","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clinimag.2025.110463_bb0040","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s12328-020-01146-z","article-title":"Robot-assisted combined pancreatectomy\/hepatectomy for metastatic pancreatic acinar cell carcinoma: case report and review of the literature","volume":"13","author":"Villano","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0045","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/MPA.0000000000002150","article-title":"Exceptional response of pancreatic acinar cell carcinoma and bile duct cancer to platinum-based chemotherapy in a family with a germline BRCA2 variant","volume":"51","author":"Sunami","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.clinimag.2025.110463_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40792-023-01729-1","article-title":"A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX","volume":"9","author":"Yamada","year":"2023","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.clinimag.2025.110463_bb0055","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.21037\/jgo.2017.06.21","article-title":"Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy","volume":"8","author":"Jordan","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0060","series-title":"Liver Metastases in Pancreatic Acinar Cell Carcinoma Treated with Selective Internal Radiation Therapy with Y-90 Resin Microspheres, Case Reports in Hepatology","first-page":"1","volume":"2017","author":"Nasser","year":"2017"},{"key":"10.1016\/j.clinimag.2025.110463_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.clinimag.2025.110463_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.clinimag.2025.110463_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinimag.2025.110463_bb0080","unstructured":"Protocol Development | CTEP, (n.d.). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm (accessed November 13, 2024)."},{"key":"10.1016\/j.clinimag.2025.110463_bb0085","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2015.64.0821","article-title":"Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone","volume":"34","author":"Brown","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.clinimag.2025.110463_bb0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jvir.2023.10.025","article-title":"Yttrium-90 transarterial radioembolization of primary lung cancer metastases to the liver","volume":"35","author":"Alexander","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0095","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0100","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","article-title":"Yttrium-90 microspheres: radiation therapy for unresectable liver cancer","volume":"13","author":"Salem","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0105","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1200\/JCO.2002.02.005","article-title":"Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors","volume":"20","author":"Holen","year":"2002","journal-title":"JCO"},{"key":"10.1016\/j.clinimag.2025.110463_bb0110","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820969447","article-title":"Clinical analysis of acinar cell carcinoma of the pancreas: a single-center experience of 45 consecutive cases","volume":"27","author":"Zhou","year":"2020","journal-title":"Cancer Control"},{"key":"10.1016\/j.clinimag.2025.110463_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/11795549221090186","article-title":"Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature","volume":"16","author":"Xu","year":"2022","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.amjsurg.2010.06.004","article-title":"Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease?","volume":"202","author":"Hartwig","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.clinimag.2025.110463_bb0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s11605-007-0338-1","article-title":"Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature","volume":"12","author":"Seth","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clinimag.2025.110463_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/hpb.12326","article-title":"Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference","volume":"17","author":"Kennedy","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.clinimag.2025.110463_bb0135","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1200\/JCO.2011.40.7627","article-title":"Transarterial chemoembolization of liver metastases as symptomatic therapy of lipase hypersecretion syndrome","volume":"30","author":"Riediger","year":"2012","journal-title":"JCO"},{"key":"10.1016\/j.clinimag.2025.110463_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","article-title":"Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Edeline","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0145","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1007\/s00259-022-05920-8","article-title":"Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib","volume":"49","author":"\u00d6cal","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinimag.2025.110463_bb0150","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/1078-0432.CCR-23-0581","article-title":"A phase I\/IIa trial of Yttrium-90 radioembolization in combination with Durvalumab for locally advanced unresectable hepatocellular carcinoma","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinimag.2025.110463_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000001546","article-title":"Successful immunotherapy with PD-1 Iinhibitor for advanced pancreatic cancer: report of two cases and review of literature","author":"Qiu","year":"2024","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.clinimag.2025.110463_bb0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0168-8278(95)80103-0","article-title":"Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever","volume":"22","author":"Castells","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0165","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2214\/AJR.21.26806","article-title":"Association of cirrhosis and other patient and procedural characteristics with Postembolization syndrome after bland hepatic artery embolization for hepatic malignancy","volume":"218","author":"Rmilah","year":"2022","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.brachy.2013.05.008","article-title":"Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: an evaluation of 112 patients","volume":"12","author":"Peterson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clinimag.2025.110463_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00198","article-title":"Side effects of Yttrium-90 radioembolization","volume":"4","author":"Riaz","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jvir.2010.10.014","article-title":"Pyogenic abscess after hepatic artery embolization: a rare but potentially lethal complication","volume":"22","author":"Mezhir","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0185","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jamcollsurg.2010.03.004","article-title":"Current management of pyogenic liver abscess: surgery is now second-line treatment","volume":"210","author":"Mezhir","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clinimag.2025.110463_bb0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00534-007-1302-x","article-title":"Complications after pancreaticoduodenectomy: intraabdominal abscess","volume":"15","author":"Schulick","year":"2008","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"10.1016\/j.clinimag.2025.110463_bb0195","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1051-0443(07)61577-2","article-title":"Risk factors for liver abscess formation after hepatic chemoembolization","volume":"12","author":"Kim","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2025.110463_bb0200","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/0300060518816875","article-title":"Liver abscesses after transcatheter arterial embolization","volume":"47","author":"Arslan","year":"2019","journal-title":"J Int Med Res"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:30:35Z","timestamp":1762317035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707125000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"alternative-id":["S0899707125000634"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110463","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of transarterial therapies for pancreatic acinar cell carcinoma metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110463"}}